Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Registration

A Notice by the Drug Enforcement Administration on 12/04/2007

Document Details

Information about this document as published in the Federal Register.

Printed version:
PDF
Publication Date:
12/04/2007
Agencies:
Drug Enforcement Administration
Document Type:
Notice
Document Citation:
72 FR 68193
Page:
68193-68195 (3 pages)
Document Number:
E7-23508
Document Details
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated August 16, 2007, and published in the Federal Register on August 28, 2007, (72 FR 49315-49316), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Start Printed Page 68194

DrugSchedule
Cathinone (1235)I
Methcathinone (1237)I
N-Ethylamphetamine (1475)I
N,N-Dimethylamphetamine (1480)I
Aminorex (1585)I
4-Methylaminorex (cis isomer) (1590)I
Gamma-Hydroxybutyric acid (2010)I
Methaqualone (2565)I
Alpha-Ethyltryptamine (7249)I
Lysergic acid diethylamide (7315)I
Marihuana (7360)I
Tetrahydrocannabinols (7370)I
Mescaline (7381)I
3,4,5-Trimethoxyamphetamine (7390)I
4-Bromo-2,5-dimethoxyamphetamine (7391)I
4-Bromo-2,5-dimethoxyphenethylamine (7392)I
4-Methyl-2,5-dimethoxyamphetamine (7395)I
2,5-Dimethoxyamphetamine (7396)I
2,5-Dimethoxy-4-ethylamphetamine (7399)I
3,4-Methylenedioxyamphetamine (7400)I
5-Methoxy-3,4-methylenedioxyamphetamine (7401)I
N-Hydroxy-3,4-methylendioxyamphetamine (7402)I
3,4-Methylendioxy-N-ethylamphetamine (7404)I
3,4-Methylenedioxymethamphetamine (7405)I
4-Methoxyamphetamine (7411)I
Alpha-methyltryptamine (7432)I
Bufotenine (7433)I
Diethyltryptamine (7434)I
Dimethyltryptamine (7435)I
Psilocybin (7437)I
Psilocyn (7438)I
Acetyldihydrocodeine (9051)I
Benzylmorphine (9052)I
Codeine-N-oxide (9053)I
Dihydromorphine (9145)I
Heroin (9200)I
Hydromorphinol (9301)I
Methyldihydromorphine (9304)I
Morphine-N-oxide (9307)I
Normorphine (9313)I
Pholcodine (9314)I
Acetylmethadol (9601)I
Allylprodine (9602)I
Alphacetylmethadol except levo-alphacetylmethadol (9603)I
Alphameprodine (9604)I
Alphamethadol (9605)I
Betacetylmethadol (9607)I
Betameprodine (9608)I
Betamethadol (9609)I
Betaprodine (9611)I
Hydroxypethidine (9627)I
Noracymethadol (9633)I
Norlevorphanol (9634)I
Normethadone (9635)I
Trimeperidine (9646)I
Phenomorphan (9647)I
Para-Fluorofentanyl (9812)I
3-Methylfentanyl (9813)I
Alpha-Methylfentanyl (9814)I
Acetyl-alpha-methylfentanyl (9815)I
Beta-hydroxyfentanyl (9830)I
Beta-hydroxy-3-methylfentanyl (9831)I
Alpha-Methylthiofentanyl (9832)I
3-Methylthiofentanyl (9833)I
Thiofentanyl (9835)I
Amphetamine (1100)II
Methamphetamine (1105)II
Phenmetrazine (1631)II
Methylphenidate (1724)II
Ambobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
Glutethimide (2550)II
Nabilone (7379)II
Start Printed Page 68195
1-Phenylcyclohexylamine (7460)II
Phencyclidine (7471)II
1-Piperidinocyclohexanecarbonitrile (8603)II
Alphaprodine (9010)II
Cocaine (9041)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Diphenoxylate (9170)II
Benzoylecgonine (9180)II
Ethylmorphine (9190)II
Hydrocodone (9193)II
Levomethorphan (9210)II
Levorphanol (9220)II
Isomethadone (9226)II
Meperidine (9230)II
Methadone (9250)II
Methadone intermediate (9254)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Morphine (9300)II
Thebaine (9333)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Racemethorphan (9732)II
Alfentanil (9737)II
Sufentanil (9740)II
Fentanyl (9801)II

The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cerilliant Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Start Signature

Dated: November 26, 2007.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. E7-23508 Filed 12-3-07; 8:45 am]

BILLING CODE 4410-09-P

Published Document